A COMPARISON OF LONG-ACTING INJECTABLE MEDICATIONS FOR SCHIZOPHRENIA.

Trial Profile

A COMPARISON OF LONG-ACTING INJECTABLE MEDICATIONS FOR SCHIZOPHRENIA.

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 Oct 2016

At a glance

  • Drugs Haloperidol decanoate; Paliperidone
  • Indications Schizoaffective disorder; Schizophrenia
  • Focus Therapeutic Use
  • Acronyms ACLAIMS
  • Most Recent Events

    • 06 Sep 2016 Status changed from active, no longer recruiting to completed.
    • 07 Apr 2015 According to the planned end date changed from 1 May 2014 to 1 Jul 2016.
    • 12 May 2014 Results published in the JAMA: the Journal of the American Medical Association.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top